ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $240,882 | -18.1% | 44,199 | +0.9% | 0.13% | -19.3% |
Q2 2023 | $294,049 | -21.5% | 43,823 | +3.3% | 0.16% | -26.5% |
Q1 2023 | $374,670 | +19.1% | 42,432 | +3.0% | 0.22% | +7.9% |
Q4 2022 | $314,703 | +11.6% | 41,192 | +3.9% | 0.20% | +8.0% |
Q3 2022 | $282,000 | +141.0% | 39,658 | +173.5% | 0.19% | +113.6% |
Q2 2022 | $117,000 | -41.5% | 14,500 | +0.8% | 0.09% | -27.9% |
Q1 2022 | $200,000 | -50.1% | 14,387 | +0.6% | 0.12% | -45.8% |
Q4 2021 | $401,000 | -18.5% | 14,297 | -1.2% | 0.22% | -19.1% |
Q3 2021 | $492,000 | -18.1% | 14,470 | -1.6% | 0.28% | -18.0% |
Q2 2021 | $601,000 | +2.0% | 14,711 | +0.5% | 0.34% | -10.3% |
Q1 2021 | $589,000 | -32.1% | 14,636 | -0.3% | 0.38% | -38.6% |
Q4 2020 | $868,000 | – | 14,683 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |